Trial Profile
Clinical Trials Insight: 700028407
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jan 2010
Price :
$35
*
At a glance
- Drugs PRX 07034 (Primary)
- Indications Alzheimer's disease; Obesity
- Focus Adverse reactions
- Sponsors EPIX Pharmaceuticals
- 13 Nov 2007 New trial record.